Clinical Trial Update: PRP vs Bevacizumab for PDR Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing panretinal photocoagulation (PRP) with Bevacizumab for proliferative diabetic retinopathy has completed. The study is sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Marashi Eye Clinic | Conditions: Proliferative Diabetic Retinopathy | Phase 2, Phase 3 | Status: COMPLETED